Evaluation of CCN3 as an Inflammatory Marker of Disease Activity in Rheumatoid Arthritis Patients

Evaluation of Subclinical Peripheral Neuropathy in Ankylosing Spondylitis Patients on Biological Treatment

Determination of miRNA -125b expression in Ankylosing Spondylitis

Evaluation of Serum Level of Sclerostin in Patients with Psoriatic Arthritis

EVALUATION OF SERUM INTERLEUKIN-34, AS A MARKER OF DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS PATIENTS

Serum Level of Interleukin-33 in Ankylosing Spondylitis Patients and Its Relation with Disease Parameters

Circulating Dickkopf-1 Levels in Ankylosing Spondylitis: Correlation with Disease Activity

SPONDYLODISCITIS DESEASE EVALUATION IN PATIENTS WITH SERONEGATIVESPONDYLOARTHROPATHIES

Evaluation of Serum Protein 14-3-3 Eta as a Novel Biomarker for Juvenile Idiopathic Arthritis

Blood Cell Indices in Ankylosing Spondylitis and Psoriatic Arthritis with Relation to the Disease Activity: A Cross-Sectional Study